Showing posts with label Tobramycin is an aminoglycoside antibiotic. Show all posts
Showing posts with label Tobramycin is an aminoglycoside antibiotic. Show all posts

Wednesday, June 12, 2013

FDA Approves TOBI Podhaler

We know that, Tobramycin is an aminoglycoside antibiotic derived from Streptomyces tenebrarius and used to treat various types of bacteria infections, particularly Gram-negative infections. It is especially effective against species of Pseudomonas.

 

The U.S. Food and Drug Administration today approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic fibrosis patients with Pseudomonas aeruginosa, a bacterium that causes lung infections.